Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Regulus Therapeutics Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 6.32||$ 14.50|
|Low||$ 5.7692||$ 5.14|
The current last sale of $5.84 is 13.62% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a biopharmaceutical company focused on discovering and developing first-in-class drugs that target microRNAs to treat a broad range of diseases. We were formed in 2007 when Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc.(formerly Isis Pharmaceuticals, Inc.) contributed significant intellectual property, know-how and financial and human capital to pursue the development of drugs targeting microRNAs pursuant to a license and collaboration agreement. We have established strategic alliances with AstraZeneca AB and Sanofi to discover, develop and commercialize microRNA therapeutics. microRNAs are naturally occurring ribonucleic acid, or RNA, molecules that play a critical role in regulating key biological pathways. Scientific research has shown that the improper balance, or dysregulation, of microRNAs is directly linked to many diseases. ... More ...
Where does RGLS fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-1.04|
|Quarterly EPS Est:||-0.33|